iBio


iBio is developing plant-based Virus Like Particles (VLP) for the treatment of SARS-CoV-2 using its FastPharming System (in collaboration with Texas A&M University System)
Rankings by

Национальный рейтинг343rd
in United States Региональный рейтинг387th
in North America and Caribbean Глобальный рейтинг928th
worldwide